Valeant: Here Come the Buyers?
May 27, 2016 at 12:49 PM EDT
S&P Global Market Intelligence's Jeffrey Loo explains why he's maintaining his Buy rating on Valeant Pharmaceuticals International ( VRX ) following reports it had rejected a takeover bid earlier this year:
